has been showing consistent strength both fundamentally and technically. Here’s what stands out: Fundamental Highlights Strong EPS Growth (TTM) – profits per share rising steadily. ROE & RoCE improving for the past 3 years → efficient use of shareholder funds and capital. Net Profit Growth: Increasing along with rising profit margins (QoQ & YoY). Low & reducing debt – balance sheet strength improving. Consistent revenue growth in the last 2 quarters. Annual EPS & Book Value improving for 2 consecutive years. Zero promoter pledge – a strong vote of confidence. Technical Signals Stock trading above 20 DMA, 50 DMA, and 200 DMA → bullish momentum. Near 52-week high – reflects positive investor sentiment. Points to Note High PE (over 40): Investors are paying a premium, so growth expectations are already high. FII/FPI shareholding declined last quarter – something to keep an eye on. 3-Year CAGR Growth Revenue: 10.25% Net Profit: 9.78% Operating Profit: 10.53% Key Takeaway: Torrent Pharma is a strong performer with improving profitability, low debt, and bullish technicals. However, valuations are expensive, so monitoring future earnings growth is crucial.

#StockInNews#FundamentalViews

887 likes·69 comments